跳至主要内容
临床试验/CTRI/2022/02/039925
CTRI/2022/02/039925尚未招募未知

Evaluation of cellular immunity in SARS-CoV-2recovered and/or vaccinated subjects to SARS-CoV-2 B-1.1.529 (OMICRON) variant by a simple Cellular Immunity Test (SCIT)

Atrimed Pharmaceuticals Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1)Both male and female adult populations aged from 18 to 60 years with or without background co-morbidities 2)Convalescent, Rapid antigen test (RAT) negative for SARS-CoV2, IgG positive or negative, vaccinated for SARS CoV2 3) Unexposed, Rapid antigen test (RAT) negative for SARS-CoV2, IgG positive or negative, vaccinated either with COVAXIN or COVISHIELD for SARS CoV2 4) Volunteer is willing and able to comply with all the trial requirements 5) All volunteers obtained written informed consent form in English as well as native language, Kannada

排除标准

  • 1) Patients with active COVID-19 infection (RAT positive)
  • 2) Known patients of HIV, Hepatitis-B/C, H1N1
  • 3) Pregnant and lactating women
  • 4) Patients with known autoimmune diseases on immunosuppressants and steroids
  • 5) Patients who have participated in another clinical trial within the previous 30 days
  • 6) Patient not willing to give informed consent

研究者

发起方
Atrimed Pharmaceuticals Pvt Ltd

相似试验

EVALUATION OF CELLULAR IMMUNITY IN SARS-CoV-2... | 临床试验